Study Details New ctDNA Isolation Method for Liquid Biopsy
VolitionRx has published peer-reviewed data on its Capture-Seq technology, reporting over 99% pure ctDNA isolation from plasma and 95% detection of early-stage cancers in validation cohorts.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
Alveo Technologies and UTMB Partner to Develop Point-of-Care Lassa Fever Diagnostics
Alveo Technologies and UTMB have partnered to develop point-of-care diagnostics for Lassa fever, deploying molecular sensing platforms at clinical sites in Nigeria and Sierra Leone to support real-time pathogen detection.
Molecular Diagnostics
Latest
En Carta Diagnostics Raises €5 Million to Advance At-Home Molecular Diagnostics, Starting With Lyme Disease
The funding will support regulatory certification and the commercial launch of rapid tests for Lyme disease and sexually transmitted infections.
CareDx Completes Acquisition of Cancer Diagnostic Company
The deal adds a blood-based test for viral-mediated cancers to the company’s portfolio of transplant and cell therapy services.
Read More
Epigenetic Tests Reduce Reliance on Self-Reported Smoking and Alcohol Use in Clinical Trials
Behavioral Diagnostics and Versiti Clinical Trial Solutions have partnered to provide epigenetic assays for objective smoking and alcohol exposure screening in clinical trials, aiming to improve participant risk assessment and data reliability.
Read More
FDA-Cleared Molecular Test Targets Growing US Cyclospora Outbreak
QIAGEN’s FDA-cleared QIAstat-Dx panel detects Cyclospora cayetanensis, addressing a surge of over 1,600 confirmed US cases since May 2026.
Read More
Researchers Develop Electronic Genome Mapping Assay for FSHD Diagnosis
Nabsys and Leiden University Medical Center are collaborating to evaluate an electronic genome mapping assay for improved detection of FSHD-associated repeat contractions, aiming to address current diagnostic limitations.
Read More
Roche Introduces Automated Test for Hepatitis D Virus
The fully automated, high-throughput assay for Hepatitis D virus RNA is available on cobas 5800/6800/8800 systems in CE mark-accepting countries.
Read More
Bio-Rad Releases New Quality Control Kits for Cell and Gene Therapy
Bio-Rad has launched Vericheck ddPCR kits for quality control in cell and gene therapy manufacturing, offering validated workflows for mycoplasma detection, capsid analysis, and residual DNA quantification.
Read More
Caris Life Sciences Launches New Blood Test for Early Cancer Detection
The test utilizes genomic sequencing and AI to identify biological signals associated with early-stage disease.
Read More
Eurobio Scientific Finalizes Acquisition of CareDx Lab Product Division
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
Read More
Single-Cell Sequencing May Identify New Exercise Biomarkers
Research suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine.
Read More
HerAnova Presents Validation Data for Endometriosis Blood Test
HerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
Read More
Roche Launches New DNA Sequencing Platform AXELIOS 1
Roche has launched AXELIOS 1, a single-molecule sequencing platform that uses sequencing by expansion technology to deliver same-day whole-genome results.
Read More
Countable Labs and Promega Partner for Sample Preparation and Rare Variant Detection
The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read More
Watchmaker Genomics Launches Tools to Streamline Sequencing Workflows
The new technologies address library normalization and amplification accuracy for high-throughput and oncology sequencing.
Read More
Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
Read More
New Clinical Guidelines Recommend Molecular Testing for Bladder Cancer
The NCCN has updated its bladder cancer guidelines to include FDA-approved ctDNA-based MRD testing for post-surgical risk assessment and adjuvant immunotherapy decisions in muscle-invasive bladder cancer.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- ...
- 108